Exosomes Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

Report Code: HCR 75368 Report Format: PDF + Excel

Exosomes Market Overview

Exosomes Market size is estimated to reach $528million by 2027, growing at a CAGR of 30.2% during the forecast period 2022-2027. Exosomes are really small bubbles/vesicles even miniature than a bacterium discharged from the cells. When MVB (= Multivesicular body) amalgamate with the Plasma membrane it produces extracellular vesicles i.e., exosomes. Diameters of exosomes are 30- 150 nm, in simple words one-millionth of the size of hair. Exosomes convey all the genetic signals necessary to alter the behavior of a bordering cell and empower cell communication. Therefore, exosomes play a significant role in the treatment of HCC (= Hepatocellular carcinoma a liver cancer), and permit cells to get rid of redundant protein. Researchers around the globe are learning and studying exosomes for diagnostic purposes and the treatment of cancer cells. Soaring uses of exosomes in the treatment of ailments such as cancer, upsurge in the pervasiveness of cancer, technological advancement in the medical field are a few factors set to drive the growth of the Exosomes Industry for the period 2022-2027. 

Report Coverage:

The report: “Exosomes Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Exosomes Market. 
By Product: Apparatuses, Gears, and reactant/reagents.
By Cancer Application: Kidney cancer, Thyroid cancer, Prostate cancer, HCC (= Hepatocellular carcinoma) liver cancer, Breast cancer, lung cancer, Throat cancer 
By End User: Hospitals, Pharmaceutical Firms, Research Bodies/Institutions, Testing Clinics
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways:

  • Geographically, the North America Exosomes Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the rise in awareness about the presence of state-of-the-art research laboratories. Furthermore, the countries such as Canada and USA allocate up to 18-20% of their budget for medical development and advancements.
  • The increase in the prevalence of cancer, and exosomes application in curing it is driving the Exosomes Market. However, rigorous government protocols such as consent for the practice of exosomes as curative reagents are one of the major factors that are said to reduce the growth of the Exosomes Market.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Exosomes Market report.
Exosomes Market- Geography (%) for 2021.
Exosomes Market
For more details on this report - Request for Sample

Exosomes Market Segment Analysis-By Cancer Application

The Exosomes Market based on the Cancer Application can be further segmented into Kidney cancer, Thyroid cancer, Prostate cancer, HCC (= Hepatocellular carcinoma) liver cancer, Breast cancer, lung cancer, Throat cancer. The lung cancer segment held the largest share in 2021 owing to the factors such as an upsurge in cases of lung cancer due to expansion in the smoking trend among youngsters, increasing pollution. As per the AQI index of various countries, predominant regions have AQI above 101, a pre-approved standard by WHO for a disease-free life. However, as per the latest data study, countries such as India have 20 states who have the AQI index termed “really poor.” Owing to such trends worldwide, the segment took hold.

Lung cancer along with the throat and liver segment is estimated to be the fastest-growing segment with a CAGR of 30.9% over the period 2022-2027. This growth is owing to factors such as wide-spreading cases of the above-mentioned types of cancers, upsurging poor ingestion habits of people, swelling usage of alcohol to deal with depression, Increase in funding by the government and institutions in the field of research and development. 

Exosomes Market Segment Analysis-By End User

The Exosomes Market based on the End User can be further segmented into Hospitals, Pharmaceutical Firms, Research Bodies/Institutions, Testing Clinics. The Research Bodies/Institutions segment held the largest share in 2021 owing to the factors such as the innumerable amount of capital into research and developments of various contemporary tools and techniques which will help in isolating exosomes, breakthroughs in the discovery of drugs. For example, Incyte’s R&D expense jumped to $2.216 billion from the earlier $1.15 billion in 2019. Additionally, the companies have been outsourcing a major chunk of research pertaining activities, which has further allowed them to hold a position.

Moreover, the research bodies segment is estimated to be the fastest-growing segment with a CAGR of 31.1% over the forecast period 2022-2027. This growth is owing to sweeping enlargement in cancer patients which is fueling the demand for advanced tools and techniques for research purposes, increasing trend of digitalization in developed as well as developing countries, liberty to research institutes by the government bodies to conduct their research obstruction-free, Heavy flows of capital/investment to strike breakthroughs.

Exosomes Market Segment Analysis-By Geography 

The Exosomes based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 35% of the overall market in 2021. The growth in this segment is owing to the factors such as affluent economy ensuing innumerable amounts of hard cash into setting up research laboratories with world-class facilities, presence of premier institutions like MIT, Harvard, etc., surfeit flows of cash into research and development. Additionally, the US government pertains to providing close to 5% of the annual medical budget for R&D purposes, which helps the market to space.

However, the Asia-Pacific segment is estimated to be the fastest-growing segment over the period 2022-2027. This growth is owing to factors such as increment in cancer patients, colossal population, prospering GDPs of developing nations like Vietnam, Indonesia, India, and China ensuring a substantial amount of riches into health infrastructure, and research and development. 

Exosomes Market Drivers

The technological breakthrough in isolating exosomes and other practices are Projected to Drive Market Growth. 

There are around 2 million diagnosed cases of cancer and approximately 700,000 confirmed deaths in the US. Therefore, as the prevalence of various types of cancer is escalating various researchers around the world are putting their valuable efforts into fabricating useful tools and techniques. Nowadays, exosomes are being extracted from the milk of cows as they have proved their worth in curing breast and lungs cancer. Therefore, the demand for using exosomes in medical treatments is swelling.

Enlarging population and cases of cancer Expected to Boost Product Demand.

The global population is on swell especially the elderly population. According to a study, around 10% of the total population falls under the category of old age and the same figure is estimated to reach 13-14% in the upcoming future. Old age isn’t always soothing. Ofttimes, it comes with a profusion of maladies such as diminished immunity and problems like cancer finding a home easily inside the body which is eventually stimulating the demand for exosomes market. The estimates vary, but a failed trial can cost somewhere between $800 million to $1.4 billion.

Exosomes Market Challenges

Stringent govt policies, In-depth knowledge is Anticipated to Hamper Market Growth.

Sometimes, getting approval from government bodies for newly manufactured techniques and drugs becomes a big headache for pharmaceutical companies and takes a lot of time. On top of that, isolating exosomes isn’t an easy process. It demands an adequate amount of time, an innumerable amount of funds, laboratories with world-class facilities, and skilled labor. Therefore, the lack of skilled professionals in the field is estimated to cripple the growth of the exosomes market. Additionally, a lot of costs go on if a trial fails at a given stage.

Exosomes Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in this market. Exosomes top 10 companies include:
  1. Hitachi Chemical Diagnostics Inc.
  2. Danaher Beckman Coulter Inc.
  3. Qiagen
  4. ExoDx
  5. MBL International
  6. Novus Biologicals
  7. Lonza
  8. System Biosciences
  9. Miltenyi Biotec
  10. Thermo fisher scientific inc.

Partnerships/Product Launches: 

  • On November 2, 2021, Swiss manufacturer, “Lonza” announced that the company will acquire an exosomes manufacturing facility from a Massachusetts-based firm, “Codiak Biosciences” in return for $65 million. Codiak Biosciences retain their core business of engineering exosomes. Lonza gets global access and sub-licensable rights to Codiak’s exosome manufacturing technology, while Codiak retains its pipeline of therapeutic candidates and some engineering and drug-loading technologies related to exosomes. 
  • On August 26, 2021, A South Korea-based biotech company, “ExoCoBio” announced that the company is soon going to initiate the project, “EGMP” and commence the building of the first facility in the world for exosome-based drug manufacturing. ExoCoBio will invest approximately US $20M to build the EGMP facility whose project actually started in 2019, and after two years of intensive preparation, its construction finally began in August this year.
  • On June 2, 2020, Sarepta Therapeutics, a leader in generic medicines and Codiak BioSciences, formed an alliance and announced a global research and option agreement, whose priority would be to develop and engineer exosome therapeutics. Additionally, the processes and aim are to find gene therapy, gene editing, and even RNA technologies for rare diseases. Moreover, Codiak is eligible to receive up to $73 million upfront and in near terms alliances.

Relevant Links: 

Report Code: HCR 83941

Report Code: HCR 0195

For more Lifesciences and Healthcare related reports, please click here
1. Exosomes Market Overview
    1.1 Definitions and Scope
2. Exosomes Market- Executive Summary
3. Exosomes Market– Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis 
4. Exosomes Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Exosomes Market– Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Exosomes Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Exosomes Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Exosomes Market- By Product (Market Size –$Million/$Billion) 
    8.1 Apparatuses
    8.2 Gears, and reactant/reagents.
9. Exosomes Market- By Cancer Application (Market Size –$Million/$Billion) 
    9.1 Kidney cancer
    9.2 Thyroid cancer
    9.3 Prostate cancer
    9.4 HCC (= Hepatocellular carcinoma)
    9.5 Breast cancer
    9.6 lung cancer
    9.7 Throat cancer 
10. Exosomes Market– By End User (Market Size –$Million/$Billion) 
    10.1 Hospitals
    10.2 Pharmaceutical Firms
    10.3 Research Bodies/Institutions
    10.4 Testing Clinics
11. Exosomes Market- By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of World
        11.5.1 Middle East
        11.5.2 Africa
12. Exosomes Market- Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs, and partnerships
13. Exosomes Market– Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Exosomes Market– Key Company List by Country Premium (Premium)
15. Exosomes Market- Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"

LIST OF TABLES

1.Global Exosomes Market:Workflow Estimate Trend Analysis Market 2019-2024 ($M)
1.1 Isolation Method Market 2019-2024 ($M) - Global Industry Research
1.1.1 Isolation Method Market, 2030 Market 2019-2024 ($M)
1.1.2 Ultracentrifugation Market 2019-2024 ($M)
1.1.3 Immunocapture On Bead Market 2019-2024 ($M)
1.1.4 Precipitation Market 2019-2024 ($M)
1.1.5 Filtration Market 2019-2024 ($M)
1.2 Downstream Analysis Market 2019-2024 ($M) - Global Industry Research
1.2.1 Downstream Analysis Market, 2030 Market 2019-2024 ($M)
1.2.2 Cell Surface Marker Analysis Using Flow Cytometry Market 2019-2024 ($M)
1.2.3 Protein Analysis Using Blotting Elisa Market 2019-2024 ($M)
1.2.4 Rna Analysis With Ng Pcr Market 2019-2024 ($M)
1.2.5 Proteomic Analysis Using Mass Spectrometry Market 2019-2024 ($M)
2.Global Exosomes Market:Biomolecule Type Estimate Trend Analysis Market 2019-2024 ($M)
2.1 Non-Coding Rna Market 2019-2024 ($M) - Global Industry Research
2.1.1 Non-Coding Rna Market, 2030 Market 2019-2024 ($M)
2.2 Mrna Market 2019-2024 ($M) - Global Industry Research
2.2.1 Mrna Market, 2030 Market 2019-2024 ($M)
2.3 Protein /Peptides Market 2019-2024 ($M) - Global Industry Research
2.3.1 Proteins/Peptides Market, 2030 Market 2019-2024 ($M)
2.4 Dna Fragment Market 2019-2024 ($M) - Global Industry Research
2.4.1 Dna Fragment Market, 2030 Market 2019-2024 ($M)
2.5 Lipid Market 2019-2024 ($M) - Global Industry Research
2.5.1 Lipid Market, 2030 Market 2019-2024 ($M)
3.Global Exosomes Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
3.1 Cancer Market 2019-2024 ($M) - Global Industry Research
3.1.1 Cancer Market, 2030 Market 2019-2024 ($M)
3.2 Neurodegenerative Disease Market 2019-2024 ($M) - Global Industry Research
3.2.1 Neurodegenerative Disease Market, 2030 Market 2019-2024 ($M)
3.3 Cardiovascular Disease Market 2019-2024 ($M) - Global Industry Research
3.3.1 Cardiovascular Disease Market, 2030 Market 2019-2024 ($M)
3.4 Infectious Disease Market 2019-2024 ($M) - Global Industry Research
3.4.1 Infectious Disease Market, 2030 Market 2019-2024 ($M)
4.Global Exosomes Market:Workflow Estimate Trend Analysis Market 2019-2024 (Volume/Units)
4.1 Isolation Method Market 2019-2024 (Volume/Units) - Global Industry Research
4.1.1 Isolation Method Market, 2030 Market 2019-2024 (Volume/Units)
4.1.2 Ultracentrifugation Market 2019-2024 (Volume/Units)
4.1.3 Immunocapture On Bead Market 2019-2024 (Volume/Units)
4.1.4 Precipitation Market 2019-2024 (Volume/Units)
4.1.5 Filtration Market 2019-2024 (Volume/Units)
4.2 Downstream Analysis Market 2019-2024 (Volume/Units) - Global Industry Research
4.2.1 Downstream Analysis Market, 2030 Market 2019-2024 (Volume/Units)
4.2.2 Cell Surface Marker Analysis Using Flow Cytometry Market 2019-2024 (Volume/Units)
4.2.3 Protein Analysis Using Blotting Elisa Market 2019-2024 (Volume/Units)
4.2.4 Rna Analysis With Ng Pcr Market 2019-2024 (Volume/Units)
4.2.5 Proteomic Analysis Using Mass Spectrometry Market 2019-2024 (Volume/Units)
5.Global Exosomes Market:Biomolecule Type Estimate Trend Analysis Market 2019-2024 (Volume/Units)
5.1 Non-Coding Rna Market 2019-2024 (Volume/Units) - Global Industry Research
5.1.1 Non-Coding Rna Market, 2030 Market 2019-2024 (Volume/Units)
5.2 Mrna Market 2019-2024 (Volume/Units) - Global Industry Research
5.2.1 Mrna Market, 2030 Market 2019-2024 (Volume/Units)
5.3 Protein /Peptides Market 2019-2024 (Volume/Units) - Global Industry Research
5.3.1 Proteins/Peptides Market, 2030 Market 2019-2024 (Volume/Units)
5.4 Dna Fragment Market 2019-2024 (Volume/Units) - Global Industry Research
5.4.1 Dna Fragment Market, 2030 Market 2019-2024 (Volume/Units)
5.5 Lipid Market 2019-2024 (Volume/Units) - Global Industry Research
5.5.1 Lipid Market, 2030 Market 2019-2024 (Volume/Units)
6.Global Exosomes Market:Application Estimate Trend Analysis Market 2019-2024 (Volume/Units)
6.1 Cancer Market 2019-2024 (Volume/Units) - Global Industry Research
6.1.1 Cancer Market, 2030 Market 2019-2024 (Volume/Units)
6.2 Neurodegenerative Disease Market 2019-2024 (Volume/Units) - Global Industry Research
6.2.1 Neurodegenerative Disease Market, 2030 Market 2019-2024 (Volume/Units)
6.3 Cardiovascular Disease Market 2019-2024 (Volume/Units) - Global Industry Research
6.3.1 Cardiovascular Disease Market, 2030 Market 2019-2024 (Volume/Units)
6.4 Infectious Disease Market 2019-2024 (Volume/Units) - Global Industry Research
6.4.1 Infectious Disease Market, 2030 Market 2019-2024 (Volume/Units)
7.North America Exosomes Market:Workflow Estimate Trend Analysis Market 2019-2024 ($M)
7.1 Isolation Method Market 2019-2024 ($M) - Regional Industry Research
7.1.1 Isolation Method Market, 2030 Market 2019-2024 ($M)
7.1.2 Ultracentrifugation Market 2019-2024 ($M)
7.1.3 Immunocapture On Bead Market 2019-2024 ($M)
7.1.4 Precipitation Market 2019-2024 ($M)
7.1.5 Filtration Market 2019-2024 ($M)
7.2 Downstream Analysis Market 2019-2024 ($M) - Regional Industry Research
7.2.1 Downstream Analysis Market, 2030 Market 2019-2024 ($M)
7.2.2 Cell Surface Marker Analysis Using Flow Cytometry Market 2019-2024 ($M)
7.2.3 Protein Analysis Using Blotting Elisa Market 2019-2024 ($M)
7.2.4 Rna Analysis With Ng Pcr Market 2019-2024 ($M)
7.2.5 Proteomic Analysis Using Mass Spectrometry Market 2019-2024 ($M)
8.North America Exosomes Market:Biomolecule Type Estimate Trend Analysis Market 2019-2024 ($M)
8.1 Non-Coding Rna Market 2019-2024 ($M) - Regional Industry Research
8.1.1 Non-Coding Rna Market, 2030 Market 2019-2024 ($M)
8.2 Mrna Market 2019-2024 ($M) - Regional Industry Research
8.2.1 Mrna Market, 2030 Market 2019-2024 ($M)
8.3 Protein /Peptides Market 2019-2024 ($M) - Regional Industry Research
8.3.1 Proteins/Peptides Market, 2030 Market 2019-2024 ($M)
8.4 Dna Fragment Market 2019-2024 ($M) - Regional Industry Research
8.4.1 Dna Fragment Market, 2030 Market 2019-2024 ($M)
8.5 Lipid Market 2019-2024 ($M) - Regional Industry Research
8.5.1 Lipid Market, 2030 Market 2019-2024 ($M)
9.North America Exosomes Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
9.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
9.1.1 Cancer Market, 2030 Market 2019-2024 ($M)
9.2 Neurodegenerative Disease Market 2019-2024 ($M) - Regional Industry Research
9.2.1 Neurodegenerative Disease Market, 2030 Market 2019-2024 ($M)
9.3 Cardiovascular Disease Market 2019-2024 ($M) - Regional Industry Research
9.3.1 Cardiovascular Disease Market, 2030 Market 2019-2024 ($M)
9.4 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
9.4.1 Infectious Disease Market, 2030 Market 2019-2024 ($M)
10.South America Exosomes Market:Workflow Estimate Trend Analysis Market 2019-2024 ($M)
10.1 Isolation Method Market 2019-2024 ($M) - Regional Industry Research
10.1.1 Isolation Method Market, 2030 Market 2019-2024 ($M)
10.1.2 Ultracentrifugation Market 2019-2024 ($M)
10.1.3 Immunocapture On Bead Market 2019-2024 ($M)
10.1.4 Precipitation Market 2019-2024 ($M)
10.1.5 Filtration Market 2019-2024 ($M)
10.2 Downstream Analysis Market 2019-2024 ($M) - Regional Industry Research
10.2.1 Downstream Analysis Market, 2030 Market 2019-2024 ($M)
10.2.2 Cell Surface Marker Analysis Using Flow Cytometry Market 2019-2024 ($M)
10.2.3 Protein Analysis Using Blotting Elisa Market 2019-2024 ($M)
10.2.4 Rna Analysis With Ng Pcr Market 2019-2024 ($M)
10.2.5 Proteomic Analysis Using Mass Spectrometry Market 2019-2024 ($M)
11.South America Exosomes Market:Biomolecule Type Estimate Trend Analysis Market 2019-2024 ($M)
11.1 Non-Coding Rna Market 2019-2024 ($M) - Regional Industry Research
11.1.1 Non-Coding Rna Market, 2030 Market 2019-2024 ($M)
11.2 Mrna Market 2019-2024 ($M) - Regional Industry Research
11.2.1 Mrna Market, 2030 Market 2019-2024 ($M)
11.3 Protein /Peptides Market 2019-2024 ($M) - Regional Industry Research
11.3.1 Proteins/Peptides Market, 2030 Market 2019-2024 ($M)
11.4 Dna Fragment Market 2019-2024 ($M) - Regional Industry Research
11.4.1 Dna Fragment Market, 2030 Market 2019-2024 ($M)
11.5 Lipid Market 2019-2024 ($M) - Regional Industry Research
11.5.1 Lipid Market, 2030 Market 2019-2024 ($M)
12.South America Exosomes Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
12.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
12.1.1 Cancer Market, 2030 Market 2019-2024 ($M)
12.2 Neurodegenerative Disease Market 2019-2024 ($M) - Regional Industry Research
12.2.1 Neurodegenerative Disease Market, 2030 Market 2019-2024 ($M)
12.3 Cardiovascular Disease Market 2019-2024 ($M) - Regional Industry Research
12.3.1 Cardiovascular Disease Market, 2030 Market 2019-2024 ($M)
12.4 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
12.4.1 Infectious Disease Market, 2030 Market 2019-2024 ($M)
13.Europe Exosomes Market:Workflow Estimate Trend Analysis Market 2019-2024 ($M)
13.1 Isolation Method Market 2019-2024 ($M) - Regional Industry Research
13.1.1 Isolation Method Market, 2030 Market 2019-2024 ($M)
13.1.2 Ultracentrifugation Market 2019-2024 ($M)
13.1.3 Immunocapture On Bead Market 2019-2024 ($M)
13.1.4 Precipitation Market 2019-2024 ($M)
13.1.5 Filtration Market 2019-2024 ($M)
13.2 Downstream Analysis Market 2019-2024 ($M) - Regional Industry Research
13.2.1 Downstream Analysis Market, 2030 Market 2019-2024 ($M)
13.2.2 Cell Surface Marker Analysis Using Flow Cytometry Market 2019-2024 ($M)
13.2.3 Protein Analysis Using Blotting Elisa Market 2019-2024 ($M)
13.2.4 Rna Analysis With Ng Pcr Market 2019-2024 ($M)
13.2.5 Proteomic Analysis Using Mass Spectrometry Market 2019-2024 ($M)
14.Europe Exosomes Market:Biomolecule Type Estimate Trend Analysis Market 2019-2024 ($M)
14.1 Non-Coding Rna Market 2019-2024 ($M) - Regional Industry Research
14.1.1 Non-Coding Rna Market, 2030 Market 2019-2024 ($M)
14.2 Mrna Market 2019-2024 ($M) - Regional Industry Research
14.2.1 Mrna Market, 2030 Market 2019-2024 ($M)
14.3 Protein /Peptides Market 2019-2024 ($M) - Regional Industry Research
14.3.1 Proteins/Peptides Market, 2030 Market 2019-2024 ($M)
14.4 Dna Fragment Market 2019-2024 ($M) - Regional Industry Research
14.4.1 Dna Fragment Market, 2030 Market 2019-2024 ($M)
14.5 Lipid Market 2019-2024 ($M) - Regional Industry Research
14.5.1 Lipid Market, 2030 Market 2019-2024 ($M)
15.Europe Exosomes Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
15.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
15.1.1 Cancer Market, 2030 Market 2019-2024 ($M)
15.2 Neurodegenerative Disease Market 2019-2024 ($M) - Regional Industry Research
15.2.1 Neurodegenerative Disease Market, 2030 Market 2019-2024 ($M)
15.3 Cardiovascular Disease Market 2019-2024 ($M) - Regional Industry Research
15.3.1 Cardiovascular Disease Market, 2030 Market 2019-2024 ($M)
15.4 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
15.4.1 Infectious Disease Market, 2030 Market 2019-2024 ($M)
16.APAC Exosomes Market:Workflow Estimate Trend Analysis Market 2019-2024 ($M)
16.1 Isolation Method Market 2019-2024 ($M) - Regional Industry Research
16.1.1 Isolation Method Market, 2030 Market 2019-2024 ($M)
16.1.2 Ultracentrifugation Market 2019-2024 ($M)
16.1.3 Immunocapture On Bead Market 2019-2024 ($M)
16.1.4 Precipitation Market 2019-2024 ($M)
16.1.5 Filtration Market 2019-2024 ($M)
16.2 Downstream Analysis Market 2019-2024 ($M) - Regional Industry Research
16.2.1 Downstream Analysis Market, 2030 Market 2019-2024 ($M)
16.2.2 Cell Surface Marker Analysis Using Flow Cytometry Market 2019-2024 ($M)
16.2.3 Protein Analysis Using Blotting Elisa Market 2019-2024 ($M)
16.2.4 Rna Analysis With Ng Pcr Market 2019-2024 ($M)
16.2.5 Proteomic Analysis Using Mass Spectrometry Market 2019-2024 ($M)
17.APAC Exosomes Market:Biomolecule Type Estimate Trend Analysis Market 2019-2024 ($M)
17.1 Non-Coding Rna Market 2019-2024 ($M) - Regional Industry Research
17.1.1 Non-Coding Rna Market, 2030 Market 2019-2024 ($M)
17.2 Mrna Market 2019-2024 ($M) - Regional Industry Research
17.2.1 Mrna Market, 2030 Market 2019-2024 ($M)
17.3 Protein /Peptides Market 2019-2024 ($M) - Regional Industry Research
17.3.1 Proteins/Peptides Market, 2030 Market 2019-2024 ($M)
17.4 Dna Fragment Market 2019-2024 ($M) - Regional Industry Research
17.4.1 Dna Fragment Market, 2030 Market 2019-2024 ($M)
17.5 Lipid Market 2019-2024 ($M) - Regional Industry Research
17.5.1 Lipid Market, 2030 Market 2019-2024 ($M)
18.APAC Exosomes Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
18.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
18.1.1 Cancer Market, 2030 Market 2019-2024 ($M)
18.2 Neurodegenerative Disease Market 2019-2024 ($M) - Regional Industry Research
18.2.1 Neurodegenerative Disease Market, 2030 Market 2019-2024 ($M)
18.3 Cardiovascular Disease Market 2019-2024 ($M) - Regional Industry Research
18.3.1 Cardiovascular Disease Market, 2030 Market 2019-2024 ($M)
18.4 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
18.4.1 Infectious Disease Market, 2030 Market 2019-2024 ($M)
19.MENA Exosomes Market:Workflow Estimate Trend Analysis Market 2019-2024 ($M)
19.1 Isolation Method Market 2019-2024 ($M) - Regional Industry Research
19.1.1 Isolation Method Market, 2030 Market 2019-2024 ($M)
19.1.2 Ultracentrifugation Market 2019-2024 ($M)
19.1.3 Immunocapture On Bead Market 2019-2024 ($M)
19.1.4 Precipitation Market 2019-2024 ($M)
19.1.5 Filtration Market 2019-2024 ($M)
19.2 Downstream Analysis Market 2019-2024 ($M) - Regional Industry Research
19.2.1 Downstream Analysis Market, 2030 Market 2019-2024 ($M)
19.2.2 Cell Surface Marker Analysis Using Flow Cytometry Market 2019-2024 ($M)
19.2.3 Protein Analysis Using Blotting Elisa Market 2019-2024 ($M)
19.2.4 Rna Analysis With Ng Pcr Market 2019-2024 ($M)
19.2.5 Proteomic Analysis Using Mass Spectrometry Market 2019-2024 ($M)
20.MENA Exosomes Market:Biomolecule Type Estimate Trend Analysis Market 2019-2024 ($M)
20.1 Non-Coding Rna Market 2019-2024 ($M) - Regional Industry Research
20.1.1 Non-Coding Rna Market, 2030 Market 2019-2024 ($M)
20.2 Mrna Market 2019-2024 ($M) - Regional Industry Research
20.2.1 Mrna Market, 2030 Market 2019-2024 ($M)
20.3 Protein /Peptides Market 2019-2024 ($M) - Regional Industry Research
20.3.1 Proteins/Peptides Market, 2030 Market 2019-2024 ($M)
20.4 Dna Fragment Market 2019-2024 ($M) - Regional Industry Research
20.4.1 Dna Fragment Market, 2030 Market 2019-2024 ($M)
20.5 Lipid Market 2019-2024 ($M) - Regional Industry Research
20.5.1 Lipid Market, 2030 Market 2019-2024 ($M)
21.MENA Exosomes Market:Application Estimate Trend Analysis Market 2019-2024 ($M)
21.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
21.1.1 Cancer Market, 2030 Market 2019-2024 ($M)
21.2 Neurodegenerative Disease Market 2019-2024 ($M) - Regional Industry Research
21.2.1 Neurodegenerative Disease Market, 2030 Market 2019-2024 ($M)
21.3 Cardiovascular Disease Market 2019-2024 ($M) - Regional Industry Research
21.3.1 Cardiovascular Disease Market, 2030 Market 2019-2024 ($M)
21.4 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
21.4.1 Infectious Disease Market, 2030 Market 2019-2024 ($M)

LIST OF FIGURES

1.US Exosomes Market Revenue, 2019-2024 ($M)
2.Canada Exosomes Market Revenue, 2019-2024 ($M)
3.Mexico Exosomes Market Revenue, 2019-2024 ($M)
4.Brazil Exosomes Market Revenue, 2019-2024 ($M)
5.Argentina Exosomes Market Revenue, 2019-2024 ($M)
6.Peru Exosomes Market Revenue, 2019-2024 ($M)
7.Colombia Exosomes Market Revenue, 2019-2024 ($M)
8.Chile Exosomes Market Revenue, 2019-2024 ($M)
9.Rest of South America Exosomes Market Revenue, 2019-2024 ($M)
10.UK Exosomes Market Revenue, 2019-2024 ($M)
11.Germany Exosomes Market Revenue, 2019-2024 ($M)
12.France Exosomes Market Revenue, 2019-2024 ($M)
13.Italy Exosomes Market Revenue, 2019-2024 ($M)
14.Spain Exosomes Market Revenue, 2019-2024 ($M)
15.Rest of Europe Exosomes Market Revenue, 2019-2024 ($M)
16.China Exosomes Market Revenue, 2019-2024 ($M)
17.India Exosomes Market Revenue, 2019-2024 ($M)
18.Japan Exosomes Market Revenue, 2019-2024 ($M)
19.South Korea Exosomes Market Revenue, 2019-2024 ($M)
20.South Africa Exosomes Market Revenue, 2019-2024 ($M)
21.North America Exosomes By Application
22.South America Exosomes By Application
23.Europe Exosomes By Application
24.APAC Exosomes By Application
25.MENA Exosomes By Application
26.Fujifilm, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Danaher, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Lonza, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Illumina, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Thermo Fisher Scientific, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Qiagen, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Takara Bio Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Malvern Instrument Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Hitachi Chemical Diagnostics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Miltenyi Biotec, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Diagenode, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Novus Biologicals, Sales /Revenue, 2015-2018 ($Mn/$Bn)
38.New England Peptide, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
39.Biovision Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
40.Mbl International Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
41.Biocat Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)